Download the Ultimate Guide to Tracking Performance in Market Access
|
Here to make market access easier, faster, and better
The pharmaceutical sector is facing seismic challenges. Budgets are being squeezed. Payer expectations are shifting. The only way to stay one step ahead is to adapt.
Access Infinity was founded in 2014 to help pharma companies confront these challenges head-on. We began as a consulting firm to guide pharma businesses in developing and implementing effective market access and pricing strategies.
Since then, we’ve introduced our market-redefining digital tools, Access Hub, Evidence Hub and NURO to help market access teams work smarter, faster and more efficiently.
Our aim is simple: to streamline decision-making and strategy development across a pharma product’s life cycle.
The journey to faster, more efficient market access decision-making starts here.
Access Infinity’s Consulting Team experts – with a combined 250+ years of experience – have completed over 1500 market access consulting projects in 4 continents.
Shri has over 14 years industry experience, working with firms like Merck and Lundbeck, Access Partnership and Double Helix. Shri has a PhD from the Asian Institute of Technology and an MPhil from the University of Cambridge.
Ahmed has developed market access strategies for over 100 products, covering all major geographies. Ahmed holds an MPhil in Bioscience Enterprise from the University of Cambridge and an MSc in Biochemical Engineering.
Tim brings vast consultative and market access, pricing and reimbursement experience, with active leadership of over 1,500 international projects for top-10 pharmaceutical firms, and having chaired 150+ global advisory boards.
A consultant to the biopharmaceutical industry for over 20 years, Nick has trained many executives on global pricing and market access. Nick has a PhD in Medicine and Pharmacy from the University of Manchester.
Brett has worked at the highest levels of market access consultancy with a special interest in complex qualitative payer & quantitative pricing research. Brett is a University of Cambridge graduate with a background microbiology, immunology & oncology
Keshav brings over 20 years of business leadership success, advising clients on their IT and Digital strategy and leading global cross-functional teams. Keshav is an Electronics & Telecommunications Engineer with an MBA in Marketing.
Our work hasn’t gone unnoticed. We’re rapidly gaining a strong reputation across the industry, including several internationally recognised awards.
Stevie Award Small Company of the Year 2021
Top 5 Pharma Tech Company in UK 2021